Initial failure in myoblast transplantation therapy has led the way toward the isolation of muscle stem cells: potential for tissue regeneration.

[1]  B. Olwin,et al.  Pax-7 up-regulation inhibits myogenesis and cell cycle progression in satellite cells: a potential mechanism for self-renewal. , 2004, Developmental biology.

[2]  R. Levy,et al.  Absence of Major Histocompatibility Complex Class I on Neural Stem Cells Does Not Permit Natural Killer Cell Killing and Prevents Recognition by Alloreactive Cytotoxic T Lymphocytes In Vitro , 2004, Stem cells.

[3]  Freddie H Fu,et al.  Structural and functional healing of critical‐size segmental bone defects by transduced muscle‐derived cells expressing BMP4 , 2004, The journal of gene medicine.

[4]  T. Braun,et al.  Pax7 directs postnatal renewal and propagation of myogenic satellite cells but not their specification , 2004, The EMBO journal.

[5]  Freddie H. Fu,et al.  Ex vivo gene therapy-induced endochondral bone formation: comparison of muscle-derived stem cells and different subpopulations of primary muscle-derived cells. , 2004, Bone.

[6]  J. Greenberger,et al.  Modeling Stem Cell Population Growth: Incorporating Terms for Proliferative Heterogeneity , 2003, Stem cells.

[7]  N. Bresolin,et al.  Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model , 2003, The Journal of cell biology.

[8]  J. Huard,et al.  Muscle-derived stem cells: potential for muscle regeneration. , 2003, Birth defects research. Part C, Embryo today : reviews.

[9]  N. Bresolin,et al.  Cell Therapy of α-Sarcoglycan Null Dystrophic Mice Through Intra-Arterial Delivery of Mesoangioblasts , 2003, Science.

[10]  B. Zheng,et al.  Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potential , 2003, Nature Cell Biology.

[11]  Johnny Huard,et al.  The role of CD34 expression and cellular fusion in the regeneration capacity of myogenic progenitor cells , 2002, Journal of Cell Science.

[12]  D. Watt,et al.  Muscle stem cells , 2002, The Journal of pathology.

[13]  Johnny Huard,et al.  Identification of a novel population of muscle stem cells in mice , 2002, The Journal of cell biology.

[14]  J. Huard,et al.  Muscle-derived stem cells , 2002, Gene Therapy.

[15]  J. Greenberger,et al.  Mechanisms of Muscle Stem Cell Expansion with Cytokines , 2002, Stem cells.

[16]  P. Zammit,et al.  The skeletal muscle satellite cell: stem cell or son of stem cell? , 2001, Differentiation; research in biological diversity.

[17]  J. Huard,et al.  Muscle-derived stem cells: characterization and potential for cell-mediated therapy. , 2001, Blood cells, molecules & diseases.

[18]  M. Trucco,et al.  Flow cytometric characterization of myogenic cell populations obtained via the preplate technique: potential for rapid isolation of muscle-derived stem cells. , 2001, Human gene therapy.

[19]  N. Bresolin,et al.  Intraarterial Injection of Muscle-Derived Cd34+Sca-1+ Stem Cells Restores Dystrophin in mdx Mice , 2001, The Journal of cell biology.

[20]  A. Wernig,et al.  Expression of Cd34 and Myf5 Defines the Majority of Quiescent Adult Skeletal Muscle Satellite Cells , 2000, The Journal of cell biology.

[21]  M. Rudnicki,et al.  Pax7 Is Required for the Specification of Myogenic Satellite Cells , 2000, Cell.

[22]  Johnny Huard,et al.  Clonal Isolation of Muscle-Derived Cells Capable of Enhancing Muscle Regeneration and Bone Healing , 2000, The Journal of cell biology.

[23]  J. Lee,et al.  Ex Vivo Gene Therapy to Produce Bone Using Different Cell Types , 2000, Clinical orthopaedics and related research.

[24]  D. Wells,et al.  Immune responses to dystrophin: implications for gene therapy of Duchenne muscular dystrophy , 2000, Gene Therapy.

[25]  R. Karpman,et al.  Professionalism and Professional Values in Orthopaedics , 2000, Clinical orthopaedics and related research.

[26]  N. Caron,et al.  In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity. , 2000, Experimental cell research.

[27]  J. Huard,et al.  The Efficiency of Muscle-Derived Cell-Mediated Bone Formation , 2000, Cell transplantation.

[28]  N. Bresolin,et al.  Intramuscular Migration of Myoblasts Transplanted after Muscle Pretreatment with Metalloproteinases , 2000, Cell transplantation.

[29]  J. Morgan,et al.  Evidence for a myogenic stem cell that is exhausted in dystrophic muscle. , 2000, Journal of cell science.

[30]  M. Grounds,et al.  Enhanced migration and fusion of donor myoblasts in dystrophic and normal host muscle , 2000, Muscle & nerve.

[31]  J. Huard,et al.  Matching host muscle and donor myoblasts for myosin heavy chain improves myoblast transfer therapy , 2000, Gene Therapy.

[32]  M. Rudnicki,et al.  A new look at the origin, function, and "stem-cell" status of muscle satellite cells. , 2000, Developmental biology.

[33]  M. Goodell,et al.  Hematopoietic potential of stem cells isolated from murine skeletal muscle. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Mulligan,et al.  Dystrophin expression in the mdx mouse restored by stem cell transplantation , 1999, Nature.

[35]  J. Tremblay,et al.  Increased Myogenic Potential and Fusion of Matrilysin-Expressing Myoblasts Transplanted in Mice , 1999, Cell transplantation.

[36]  T. Partridge,et al.  Dynamics of Myoblast Transplantation Reveal a Discrete Minority of Precursors with Stem Cell–like Properties as the Myogenic Source , 1999, The Journal of cell biology.

[37]  J. Morgan,et al.  Muscle precursor cells injected into irradiated mdx mouse muscle persist after serial injury , 1999, Muscle & nerve.

[38]  Johnny Huard,et al.  Development of Approaches to Improve Cell Survival in Myoblast Transfer Therapy , 1998, The Journal of cell biology.

[39]  K. Okumura,et al.  Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy. , 1998, Journal of immunology.

[40]  Y. Nabeshima,et al.  Cell heterogeneity upon myogenic differentiation: down-regulation of MyoD and Myf-5 generates 'reserve cells'. , 1998, Journal of cell science.

[41]  P. Hallauer,et al.  Prior culture with concanavalin A increases intramuscular migration of transplanted myoblast , 1998, Muscle & nerve.

[42]  B. Wold,et al.  Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. , 1997, Developmental biology.

[43]  L. Kunkel,et al.  The fate of individual myoblasts after transplantation into muscles of DMD patients , 1997, Nature Medicine.

[44]  R. Bischoff.  Chemotaxis of skeletal muscle satellite cells , 1997, Developmental dynamics : an official publication of the American Association of Anatomists.

[45]  R. Roy,et al.  Role of non-major histocompatibility complex antigens in the rejection of transplanted myoblasts. , 1997, Transplantation.

[46]  J. Tremblay,et al.  Control of inflammatory damage by anti-LFA-1: increase success of myoblast transplantation. , 1997, Cell transplantation.

[47]  M. Ho,et al.  Evidence for multiple satellite cell populations and a non-myogenic cell type that is regulated differently in regenerating and growing skeletal muscle. , 1996, Tissue & cell.

[48]  G. Pari,et al.  Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice. , 1996, Gene therapy.

[49]  M. Grounds,et al.  Rapid death of injected myoblasts in myoblast transfer therapy , 1996, Muscle & nerve.

[50]  M. Grounds.  Commentary on the present state of knowledge for myoblast transfer therapy. , 1996, Cell transplantation.

[51]  E. Schultz.  Satellite cell proliferative compartments in growing skeletal muscles. , 1996, Developmental biology.

[52]  C. Bader,et al.  Identification of self-renewing myoblasts in the progeny of single human muscle satellite cells. , 1996, Differentiation; research in biological diversity.

[53]  I. Kinoshita,et al.  Successful histocompatible myoblast transplantation in dystrophin- deficient mdx mouse despite the production of antibodies against dystrophin , 1995, The Journal of cell biology.

[54]  R. R. Rice,et al.  Myoblast transfer in the treatment of Duchenne's muscular dystrophy. , 1995, The New England journal of medicine.

[55]  S. Noguchi,et al.  Dystrophin-associated proteins in muscular dystrophy. , 1995, Human molecular genetics.

[56]  S. E. Michaels,et al.  Radiation inhibition of mdx mouse muscle regeneration: Dose and age factors , 1995, Muscle & nerve.

[57]  R. Roy,et al.  Lymphocyte infiltration following allo‐and xenomyoblast transplantation in mdx mice , 1995, Muscle & nerve.

[58]  R. Roy,et al.  Very efficient myoblast allotransplantation in mice under FK506 immunosuppression , 1994, Muscle & nerve.

[59]  T. Voit,et al.  Coisogenic all-plus-one immunization: a model for identifying missing proteins in null-mutant conditions. Antibodies to dystrophin in mdx mouse after transplantation of muscle from normal coisogenic donor. , 1994, Neuropediatrics.

[60]  H. Blau,et al.  Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy , 1994, The Journal of cell biology.

[61]  J. Huard,et al.  Human myoblast transplantation in immunodeficient and immunosuppressed mice: Evidence of rejection , 1994, Muscle & nerve.

[62]  J. Tremblay,et al.  High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. , 1994, The Journal of clinical investigation.

[63]  K. Campbell,et al.  Dystrophin–glycoprotein complex: Its role in the molecular pathogenesis of muscular dystrophies , 1994, Muscle & nerve.

[64]  J. Huard,et al.  Use of fluorescent latex microspheres (FLMs) to follow the fate of transplanted myoblasts. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[65]  George Karpati,et al.  Myoblast transfer in duchenne muscular dystrophy , 1993, Annals of neurology.

[66]  T. Partridge,et al.  Long-term persistence and migration of myogenic cells injected into pre-irradiated muscles of mdx mice , 1993, Journal of the Neurological Sciences.

[67]  C. Richards,et al.  Results of a Triple Blind Clinical Study of Myoblast Transplantations without Immunosuppressive Treatment in Young Boys with Duchenne Muscular Dystrophy , 1993, Cell transplantation.

[68]  J. Ervasti,et al.  Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle , 1992, Nature.

[69]  C. Richards,et al.  Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions. , 1992, Transplantation proceedings.

[70]  R. Roy,et al.  Immune reactions after myoblast transplantation in mouse muscles. , 1992, Transplantation proceedings.

[71]  R. Naviaux,et al.  Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[72]  J. Bouchard,et al.  Human myoblast transplantation: Preliminary results of 4 cases , 1992, Muscle & nerve.

[73]  H. Blau,et al.  Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation , 1992, Nature.

[74]  O. Ibraghimov-Beskrovnaya,et al.  Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix , 1992, Nature.

[75]  J. Ervasti,et al.  Membrane organization of the dystrophin-glycoprotein complex , 1991, Cell.

[76]  J. Bouchard,et al.  Myoblast transplantation produced dystrophin-positive muscle fibres in a 16-year-old patient with Duchenne muscular dystrophy. , 1991, Clinical science.

[77]  J. Huard,et al.  Dystrophin expression in myotubes formed by the fusion of normal and dystrophic myoblasts , 1991, Muscle & nerve.

[78]  H. Jockusch,et al.  Decreased osmotic stability of dystrophin-less muscle cells from the mdx mouse , 1991, Nature.

[79]  D. Watt,et al.  X‐Irradiation improves mdx mouse muscle as a model of myofiber loss in DMD , 1991, Muscle & nerve.

[80]  E. Hoffman,et al.  Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse , 1990, The Journal of cell biology.

[81]  T. Bertorini,et al.  Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy , 1990, The Lancet.

[82]  Y. Pouliot,et al.  Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. , 1989, The American journal of pathology.

[83]  L. Kunkel,et al.  Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts , 1989, Nature.

[84]  S. Dimauro,et al.  Duchenne muscular dystrophy: Deficiency of dystrophin at the muscle cell surface , 1988, Cell.

[85]  Simon C Watkins,et al.  Immunoelectron microscopic localization of dystrophin in myofibres , 1988, Nature.

[86]  Hideo Sugita,et al.  Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide , 1988, Nature.

[87]  R. Hodges,et al.  The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle , 1988, Nature.

[88]  P. Law,et al.  Normal myoblast injections provide genetic treatment for murine dystrophy , 1988, Muscle & nerve.

[89]  M. Grounds,et al.  A model of myogenesis in vivo, derived from detailed autoradiographic studies of regenerating skeletal muscle, challenges the concept of quantal mitosis , 1987, Cell and Tissue Research.

[90]  M. Grounds,et al.  Initiation and duration of muscle precursor replication after mild and severe injury to skeletal muscle of mice , 1987, Cell and Tissue Research.

[91]  D. Watt,et al.  Use of mononuclear precursor cells to insert allogeneic genes into growing mouse muscles , 1984, Muscle & nerve.

[92]  D. Watt,et al.  Incorporation of donor muscle precursor cells into an area of muscle regeneration in the host mouse , 1982, Journal of the Neurological Sciences.

[93]  D. Yaffe,et al.  The in vitro cultivation and differentiation capacities of myogenic cell lines. , 1970, Developmental biology.

[94]  J. Huard,et al.  Establishing reliable criteria for isolating myogenic cell fractions with stem cell properties and enhanced regenerative capacity. , 2004, Blood cells, molecules & diseases.

[95]  T. Partridge,et al.  Muscle Satellite Cells Adopt Divergent Fates: a Mecha- Nism for Self-renewal? , 2004 .

[96]  Peter Parham,et al.  KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. , 2002, Annual review of immunology.

[97]  S. Dimauro,et al.  RAPID COMMUNICATION Immunocytochemical Study of Dystrophin in Muscle Culturesfrom Patients with Duchenne Muscular Dystrophy and Unaffected Control Patients , 2022 .

[98]  Eric P. Hoffman,et al.  Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.